Last reviewed · How we verify

NCT04980560

Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts

Active, enrolled Last updated 26 August 2024
What this trial tests

trial in COVID-19 Vaccination in 215 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 May 2021
Primary endpoint
17 June 2024
31 December 2025

Quick facts

Lead sponsorChinese University of Hong Kong
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment215
Start date14 May 2021
Primary completion17 June 2024
Estimated completion31 December 2025
Sites1 location across Hong Kong

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

18 and older, any sex, with COVID-19 Vaccination or Gut Microbiota. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the association between gut microbiota composition and the magnitude and duration of immune response in subjects who have received different COVID-19 vaccines in Hong Kong and to identify the differences compared to those COVID-19 recovered subjects.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The intestinal microbiota and improving the efficacy of COVID-19 vaccinations.
    Chen J, Vitetta L, Henson JD, Hall S. · · 2021 · cited 23× · PMID 34777578 · DOI 10.1016/j.jff.2021.104850
  2. Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
    Lau HC, Ng SC, Yu J. · · 2022 · cited 16× · PMID 34508775 · DOI 10.1053/j.gastro.2021.09.009
  3. A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.
    Hong M, Lan T, Li Q, Li B, et al · · 2023 · cited 13× · PMID 37431857 · DOI 10.1080/19490976.2023.2233146
  4. Modulated Gut Microbiota for Potential COVID-19 Prevention and Treatment.
    Zhao S, Feng P, Meng W, Jin W, et al · · 2022 · cited 12× · PMID 35308540 · DOI 10.3389/fmed.2022.811176

Verify or expand the search:

Other recruiting trials for COVID-19 Vaccination

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04980560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing